Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.95
-0.04 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
5.91
-0.04 (-0.67%)
After-hours: Apr 28, 2026, 6:31 PM EDT
Plus Therapeutics Stock Forecast
PSTV's stock price has decreased by -70.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Plus Therapeutics stock have an average target of 55, with a low estimate of 25 and a high estimate of 75. The average target predicts an increase of 824.37% from the current stock price of 5.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Plus Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $475 → $65 | Strong Buy | Maintains | $475 → $65 | +992.44% | Apr 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $75 | Strong Buy | Maintains | $75 | +1,160.50% | Mar 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $25 | Strong Buy | Maintains | $50 → $25 | +320.17% | Jan 23, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $125 → $100 | Strong Buy | Maintains | $125 → $100 | +1,580.67% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
5.90M
from 5.21M
Increased by 13.20%
Revenue Next Year
21.33M
from 5.90M
Increased by 261.48%
EPS This Year
-3.70
from -7.25
EPS Next Year
-2.17
from -3.70
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.9M | 29.4M | ||||||
| Avg | 5.9M | 21.3M | ||||||
| Low | 3.9M | 9.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 127.6% | 398.2% | ||||||
| Avg | 13.2% | 261.5% | ||||||
| Low | -24.8% | 66.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -2.89 | -1.84 | ||||
| Avg | -3.70 | -2.17 | ||||
| Low | -4.66 | -2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.